This invitation-only session will spotlight investment opportunities within North America's health supply chains—from medical commodities and pharmaceutical ingredients to logistics and distribution infrastructure. Participants will explore how targeted investments can fortify supply resilience, enhance domestic production capabilities, and improve responsiveness during public health crises, while benefiting from policy incentives and public–private partnerships.